share_log

HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $4 Price Target

Benzinga ·  Nov 14, 2023 11:22

HC Wainwright & Co. analyst Joseph Pantginis reiterates BioCardia (NASDAQ:BCDA) with a Buy and maintains $4 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment